Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky

Guest: Dr. Jessica Moss, MD Assistant Professor of Internal Medicine, Medical Oncology, University of Kentucky Markey Cancer Center

Cancer Conversations Episode 71

Welcome to Cancer Conversations on Talking FACS with host Mindy McCulley and guest Dr. Jessica Moss, assistant professor of internal medicine in the division of Medical Oncology at the Markey Cancer Center. In this episode Dr. Moss reviews recent advances in breast cancer care, including the incorporation of immunotherapy for triple-negative disease and new targeted therapies for stage IV patients.

Topics include how breast cancer subtypes affect treatment and prognosis; the importance of genetic counseling and testing—especially for men, young patients, and those with triple-negative tumors; common risk factors such as obesity, alcohol use, and reproductive history; and warning signs that warrant medical attention. Dr. Moss also discusses how many patients with advanced disease are living longer with improved, less-toxic options.

Key takeaways: breast cancer is not one disease, screening and awareness matter, genetic evaluation can guide care, and recent therapies are creating more personalized, hopeful outcomes.

Connect with the UK Markey Center

Online Markey Cancer Center

On Facebook @UKMarkey

On X @UKMarkey